Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PTC Therapeutics's share price for the quarter that ended in Mar. 2022 was $37.31. PTC Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Mar. 2022 was 71.3 Mil. Therefore, PTC Therapeutics's market cap for the quarter that ended in Mar. 2022 was $2,661.6 Mil.
PTC Therapeutics's quarterly market cap
increased
from Sep. 2021 ($2,629.4 Mil) to Dec. 2021 ($2,821.1 Mil) but then
declined
from Dec. 2021 ($2,821.1 Mil) to Mar. 2022 ($2,661.6 Mil).
PTC Therapeutics's annual market cap
increased
from Dec. 2019 ($2,974.8 Mil) to Dec. 2020 ($4,254.9 Mil) but then
declined
from Dec. 2020 ($4,254.9 Mil) to Dec. 2021 ($2,821.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PTC Therapeutics's Enterprise Value for Today is $2,801.5 Mil.
PTC Therapeutics Market Cap Historical Data
The historical data trend for PTC Therapeutics's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
PTC Therapeutics Annual Data
Trend
Dec12
Dec13
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Market Cap
694.09
1,736.80
2,974.78
4,254.90
2,821.09
PTC Therapeutics Quarterly Data
Jun17
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Market Cap
3,333.72
2,982.54
2,629.44
2,821.09
2,661.58
Competitive Comparison
For the Biotechnology subindustry, PTC Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PTC Therapeutics Market Cap Distribution
For the Biotechnology industry and Healthcare sector, PTC Therapeutics's Market Cap distribution charts can be found below:
* The bar in red indicates where PTC Therapeutics's Market Cap falls into.
PTC Therapeutics Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PTC Therapeutics's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PTC Therapeutics (NAS:PTCT) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companyÂ’s debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PTC Therapeutics Market Cap Related Terms
Thank you for viewing the detailed overview of PTC Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
PTC Therapeutics Inc is a global biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when a RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.51(1.27%) Volume: 404,524 2:15PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NAS:PTCT has been successfully added to your 
